256 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ALXN Alexion Pharmaceuticals, Inc. $117.77 $26.25B N/A
Article Searches
5 Discounted PEG Stocks for GARP Investors http://www.zacks.com/stock/news/655607/5-discounted-peg-stocks-for-garp-investors?cid=CS-ZC-FT-analyst_blog|rw-655607 Dec 05, 2019 - Although PEG is categorized under value investing, it follows the principles of both growth and value investing.
ALXN vs. ILMN: Which Stock Is the Better Value Option? http://www.zacks.com/stock/news/654306/alxn-vs-ilmn-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-654306 Dec 04, 2019 - ALXN vs. ILMN: Which Stock Is the Better Value Option?
Biotech Stock Roundup: CBAY Falls, CCXI Gains, Amgen Acquires Otezla & More http://www.zacks.com/stock/news/643371/biotech-stock-roundup-cbay-falls-ccxi-gains-amgen-acquires-otezla-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-643371 Nov 27, 2019 - Key highlights of the past week include regulatory and pipeline updates.
4 Big Drug Stocks Ripe for Takeover After NVS-MDCO Deal http://www.zacks.com/stock/news/638202/4-big-drug-stocks-ripe-for-takeover-after-nvs-mdco-deal?cid=CS-ZC-FT-analyst_blog|industry_focus-638202 Nov 26, 2019 - Here are four stocks that boast promising prospects and are most likely to be takeout targets.
Alexion Gets Approval for Label Expansion of Soliris in Japan http://www.zacks.com/stock/news/636828/alexion-gets-approval-for-label-expansion-of-soliris-in-japan?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-636828 Nov 25, 2019 - Alexion (ALXN) gets Japan Ministry of Health, Labour and Welfare's approval for the label expansion of Soliris.
Achillion's (ACHN) Danicopan Gets EMA's PRIME Tag for PNH http://www.zacks.com/stock/news/629256/achillions-achn-danicopan-gets-emas-prime-tag-for-pnh?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-629256 Nov 20, 2019 - Achillion's (ACHN) lead pipeline candidate danicopan receives PRIME status from the EMA as a treatment option for PNH in patients, who are not adequately responding to a C5 inhibitor.
4 Big Biotech Stocks Worth Considering Post Q3 Earnings http://www.zacks.com/stock/news/627538/4-big-biotech-stocks-worth-considering-post-q3-earnings?cid=CS-ZC-FT-analyst_blog|investment_ideas-627538 Nov 19, 2019 - We highlight a few principal players from the biotech sector, which are likely to witness a winning run in the near term.
ALXN vs. CBM: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/625587/alxn-vs-cbm-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-625587 Nov 18, 2019 - ALXN vs. CBM: Which Stock Is the Better Value Option?
What Bargain Hunting? Tap 5 Stocks With Rising P/E http://www.zacks.com/stock/news/621113/what-bargain-hunting-tap-5-stocks-with-rising-p-e?cid=CS-ZC-FT-analyst_blog|rw-621113 Nov 15, 2019 - Bet on these top-ranked stocks with rising P/E for outsized gains.
Celgene (CELG) Hits 52-Week High, Can the Run Continue? http://www.zacks.com/stock/news/614198/celgene-celg-hits-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-614198 Nov 11, 2019 - Celgene (CELG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Pages: 123456...26

Page 1>